EasyCookieInfo

PROTEIN PRODUCTION FACILITY

The Protein Production facility (PPF) gives support to internal research groups and is involved in several scientific projects.
In addition, the facility offers external services such the expression and purification of recombinant proteins both from E.Coli and insect cells.

 

WHAT WE DO AND OFFER
Set-up studies: evaluation and design of DNA constructs; screening in different E.Coli strains (BL21; Rosetta; C43); optimization of culturing conditions and purification methods (Affinity chromatography, IEX, SEC, HIC).

Protein production: small (µg) and large-scale (mg) expression and purification of recombinant proteins in E.Coli.

Baculovirus system: we have recently extended our portfolio to insect cells. We offer small-scale expression of recombinant proteins in Sf21 and High-Five™ cells using Bac-to-Bac system.

Quality controls: we perform quality protein controls which include SDS-PAGE and Western blot analysis, densitometry and mass-spec analysis.

Pre-industrial optimization process: fermentation strategies for HCDC by the pH-stat and/or DO-stat; customized media for optimal growing/expression conditions.


Takis Protein Production facility is part of the Protein Production and Purification Partnership in Europe (P4EU) which aims to improve exchange of information and to stay always up-to-date with the latest discoveries in the protein science field.


The Team

Mariano Maffei, PhD
Senior Scientist

This email address is being protected from spambots. You need JavaScript enabled to view it.

Luigi Fedele
Scientist

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Contact info: This email address is being protected from spambots. You need JavaScript enabled to view it.


Follow Us on Linkedin

Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity.